Qiagen announced an updated version of its clinical decision support platform, Qiagen Clinical Insight Interpret for NGS molecular profiling of hereditary and somatic diseases, has received the European Union, or EU, Technical Documentation Assessment and Quality Management System certificate under the European In Vitro Diagnostic Medical Device Regulation.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QGEN:
- QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support
- Qiagen announces FDA clearance for QIAstat-Dx Respiratory Panel Plus
- QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results
- Qiagen enters CRADA with FBI for QIAcuity digital PCR devices
- Qiagen Exceeds Q1 Expectations, Affirms 2024 Outlook